His plan to reclassify cannabis, so that it's no longer a Schedule I drug under the Controlled Substances Act, wouldn't make pot legal in the U.S., but it could help marijuana companies do more business. What does the research show about marijuana's harms, and does this fit Trump's call to "Make America Healthy Again"?
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Fler avsnitt av WSJ Opinion: Potomac Watch
Visa alla avsnitt av WSJ Opinion: Potomac WatchWSJ Opinion: Potomac Watch med Paul Gigot, The Wall Street Journal finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
